Dr. Milind Kamkolkar, Sanofi

Dr. Milind Kamkolkar Milind Kamkolkar is the CDO of Sanofi, a company focused on empowering lives through human health. Milind’s focus is driving and transforming Sanofi from a data generation organization to an insights generating organization where data is a monetizable asset class on par with product and shareholder value.   Milind joined Sanofi from a career spanning big pharma (Novartis), big and boutique consulting (Cognizant and PA Consulting), and numerous technology and software startup companies focused on health, technology and data mining blending insights and approaches across industries to solve complex human health problems at scale. Milind is a featured speaker and thought leader in Digital Health, AI & Big Data, serves as a Board Advisor and mentor to 3 exciting startups hacking education/mental health, deep learning for research technologies, Honorary Lecturer for physician entrepreneurship at BartsX, Faculty at Exponential Medicine and Special Advisor to the UN Global Sustainability program


4:10 PM - 4:30 PM

Fireside Chat: Getting Corporate Culture Right to Improve Business Outcome Conversations and Results

Biopharma companies are full of extremely intelligent people but they are generally lacking the specific capabilities needed to maximize the benefits of AI/ML. This discussion session is a great opportunity to share your experiences focusing on these questions and more: How do you tackle the challenge of recruiting and retaining the best technologists if you haven’t updated your technology and IT processes? What is the cultural transformation other industries have undertaken that biopharma can adopt to have business outcome conversations and not just data conversations?  How do you create a flexible culture where communication between technical and non-technical people is valued and effective?

9:25 AM - 9:55 AM

Data is the New Key Asset: An Interactive Discussion with CDOs

This session puts a spotlight on the challenges all organizations are facing, but that are particularly prevalent in healthcare organizations.  Join the conversation and help to facilitate and encourage change.  We hope by the end of this discussion you will be able to commit to 1-2 things that you can influence in your role over the next year to make progress in more effective management of your data. Discussion points include:  
  • Is it important to develop core technical capabilities in-house or can you rely heavily on consultants and outsourcing?
  • How do you move beyond legacy systems that follow a linear process of development to incorporate more effective methods like agile and sprint?
  • What resources do you need to be able to achieve a global data view to be able to make better decisions?
    • Where do you pull your data from?
    • How do you store it?
    • What is the most effective way to approach data definitions?
  • What are the ethical issues around data and data sharing that you need to be aware of?
  • What can be learned from other industries and companies like Netflix and Coca-Cola about effective data management?


  • Mike Townsend

    Mike Townsend Research Manager, Life Sciences Commercial Strategies IDC Health Insights


  • Lihua Yu, Ph.D.

    Lihua Yu, Ph.D. President, Chief Data Science Officer H3 Biomedicine Inc.

Download Latest Agenda